Patent assignee · SE · COMPANY

ATROGI AB

11Patents
11Active
11Granted
51Portfolio score

Filing activity: Dec 16, 2013 → Apr 11, 2023

Most-cited patents

PatentTitleAreaCited byStatus
US9657348B2 Method of screening compounds for the treatment of diabetes Physics 9 Active
US9784726B2 Screening method, a kit, a method of treatment and a compound for use in a method of treatment Physics 8 Active
US9891212B2 Screening method, a kit, a method of treatment and a compound for use in a method of treatment Physics 8 Active
US10288602B2 Screening method, a kit, a method of treatment and a compound for use in a method of treatement Physics 7 Active
US11357757B2 Heteroaryl substituted beta-hydroxyethylamines for use in treating hyperglycaemia Chemistry; Metallurgy 6 Active
US11427539B2 Beta-hydroxy heterocyclic amines and their use in the treatment of hyperglycaemia Chemistry; Metallurgy 2 Active
US11648216B2 Fluorophenyl beta-hydroxyethylamines and their use in the treatment of hyperglycaemia Chemistry; Metallurgy 1 Active
US11793774B2 Chiral beta-hydroxyethylamines and their use in the treatment of hyperglycemia Chemistry; Metallurgy 0 Active
US12378216B2 Heteroaryl(heterocyclyl)methanol compounds useful in the treatment of hyperglycaemia Human Necessities 0 Active
US12036210B2 Heteroaryl substituted beta-hydroxyethylamines for use in treating hyperglycaemia Chemistry; Metallurgy 0 Active
US12280023B2 Fluorophenyl beta-hydroxyethylamines and their use in the treatment of hyperglycaemia Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.